RAPT Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.046; its P/E ratio is -2.93; RAPT Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -31.37M	$ -25.28M	$ -29.27M	$ -24.43M	$ -21.68M
EBITDA	$ -32.61M	$ -26.52M	$ -30.41M	$ -24.63M	$ -21.42M
Net Income Common Stockholders	$ -31.37M	$ -25.28M	$ -29.27M	$ -22.95M	$ -21.23M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 184.78M	$ 205.00M	$ 231.63M	$ 249.07M	$ 195.44M
Total Assets	$ 199.72M	$ 220.76M	$ 248.33M	$ 266.21M	$ 209.49M
Total Debt	$ 7.46M	$ 8.00M	$ 8.53M	$ 8.99M	$ 7.87M
Net Debt	$ -177.31M	$ -197.00M	$ -223.10M	$ -240.08M	$ -187.57M
Total Liabilities	$ 26.92M	$ 21.08M	$ 27.86M	$ 21.04M	$ 20.18M
Stockholders Equity	$ 172.80M	$ 199.68M	$ 220.47M	$ 245.17M	$ 189.31M
Cash Flow	-
Free Cash Flow	$ -21.95M	$ -29.04M	$ -19.36M	$ -22.90M	$ -17.23M
Operating Cash Flow	$ -21.88M	$ -28.81M	$ -18.60M	$ -22.85M	$ -17.15M
Investing Cash Flow	$ 25.75M	$ 32.44M	$ 25.31M	$ -41.27M	$ -17.60M
Financing Cash Flow	$ 106.00K	$ 767.00K	$ 116.00K	$ 75.36M	$ 5.25M

Currency in USD

RAPT Therapeutics Earnings and Revenue History

Income Statement >

RAPT Therapeutics Debt to Assets

Balance Sheet >

RAPT Therapeutics Cash Flow

Cash Flow >

RAPT Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing